v3.26.1
Share-Based Payment (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment [Abstract]  
Schedule of Financial Statements for Services Received from Employees and Officers

The expense recognized in the financial statements for services received from employees and officers is shown in the following table:

 

   Year ended December 31, 
   2025   2024   2023 
   USD in thousands 
     
Equity-settled share-based payment plans   3,189    2,070    7,115 
Schedule of Number of Share Options and the Weighted Average Exercise Prices

The following table presents the changes in the number of share options and the weighted average exercise prices of share options: 

 

   2025   2024 
  

Number of

options

  

Weighted

average

exercise

price

  

Number of

options

  

Weighted

average

exercise

price

 
                 
Share options outstanding at beginning of year   
-
    426,000    2    1,506,000 
Share options granted during the year   
-
    
-
    
-
    
-
 
Share options exercised during the year   
-
    
-
    
-
    7,500 
Share options forfeited during the year   
-
    
-
    
-
    6,000 
Share options expired during the year   
-
    1,205,000    
-
    2,476,500 
                     
Share options outstanding at end of year   
-
    933,532    
-
    426,000 
                     
Share options exercisable at end of year   
-
    1    
-
    378,000 
Schedule of Status of RSUs

A summary of the status of RSUs under the Plan as of December 31, 2025 and changes during the relevant period ended on that date is presented below:

 

  

Number of

RSU

 
     
Outstanding at beginning of year*   1 
Granted   451 
Vested   (12)
Forfeited and cancelled   (9)
      
Outstanding at end of year   431 

 

* This includes shares granted with performance obligations which were not fulfilled as of December 31, 2025.
Schedule of Total Equity-Based Compensation Expense

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the years ended December 31, 2025, 2024 and 2023, was comprised as follows:

 

   Year ended December 31, 
   2025   2024   2023 
             
Cost of revenues   
-
    
-
    35 
Research and development expenses   163    (11)   3,010 
Sales and marketing expenses   85    (32)   211 
General and administrative expenses   2,941    2,113    3,859 
                
Total share-based payment   3,189    2,070    7,115